Combinatorial Antitumor Effect of Rapamycin and β-Elemene in Follicular Thyroid Cancer Cells

Background. mTOR signaling would be a promising target for thyroid cancer therapy. However, in clinical trials, objective response rate with mTOR inhibitor monotherapy in most cancer types was modest. A new focus on development of combinatorial strategies with rapalogs is increasing. Objective. Inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, He, Li-Li, Ding, Xiao-Fei, Yuan, Qiu-Qi, Zhang, Jian-Xin, Liu, Shuang-Chun, Chen, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870352/
https://www.ncbi.nlm.nih.gov/pubmed/27274989
http://dx.doi.org/10.1155/2016/6723807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870352/
https://www.ncbi.nlm.nih.gov/pubmed/27274989
http://dx.doi.org/10.1155/2016/6723807

Ejemplares similares